In our study we did not concurrently evaluate the p16 staining status of HGPIN in our tumor samples, thus our results are not directly comparable with these of Henshall et al. Even in this case, they do not mention whether p16 expression in areas of cancer alone independently correlated with relapse-free survival. This evidence concerns the gene CDKN2A and cancer.